Celiac disease: FDA offers guidance on drug development
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsProduct LifecycleResearch, Design and DevelopmentRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsProduct LifecycleResearch, Design and Development